Since joining the industry in 2000, Regina Hodits became an influential investor in the European VC industry, focusing on early-stage and growth deals in Life Sciences.
— Sachs Associates (@SachsAssociates) January 25, 2021
e-Meet Regina at #Sachs_EHTF
More info @ https://t.co/HI7OAD4QYO pic.twitter.com/JNRinKKTv6
